Revenue
167 thousand USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 167000 USD Source
Annual consolidated revenue for 2026: about uref_410714697 1.016M, using the latest reported figures. The previous period, 2025, was about uref_410714697 1.336M.
167 thousand USD
2026 Q3 · USD
-3,913.77%
2026 Q3 · %
-4.51 million USD
2026 Q3 · USD
-4.56 million USD
2026 Q3 · USD
3529000 uref_410714697
10824311 uref_1687574659
37.12% · 2.93 million uref_1687574659
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
1.08 million USD
2025-04-01 – 2026-03-31
-25.5 million USD
2025-04-01 – 2026-03-31
-20.4 million USD
2025-04-01 – 2026-03-31
1.33 million USD
2025-04-01 – 2026-03-31
-21.7 million USD
2025-04-01 – 2026-03-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-30.
Financial data available through: 2026-06-30.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
uref_410714697 1.34 million
–
Current period
uref_410714697 1.02 million
–
1016000 − 1336000 = -320000 uref_410714697
1336000 uref_410714697 · 2024-07-01 – 2025-06-30
Inspect prior input Prior source1016000 uref_410714697 · 2025-07-01 – 2026-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−uref_410714697 22.58 million
–
Current period
−uref_410714697 23.82 million
–
-23821000 − -22583000 = -1238000 uref_410714697
-22583000 uref_410714697 · 2024-07-01 – 2025-06-30
Inspect prior input Prior source-23821000 uref_410714697 · 2025-07-01 – 2026-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−uref_410714697 18.21 million
–
Current period
−uref_410714697 19.59 million
–
-19588000 − -18211000 = -1377000 uref_410714697
-18211000 uref_410714697 · 2024-07-01 – 2025-06-30
Inspect prior input Prior source-19588000 uref_410714697 · 2025-07-01 – 2026-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
uref_410714697 1.62 million
–
Current period
uref_410714697 633,000
–
633000 − 1618000 = -985000 uref_410714697
1618000 uref_410714697 · 2024-07-01 – 2025-06-30
Inspect prior input Prior source633000 uref_410714697 · 2025-07-01 – 2026-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2025 2024-07-01 – 2025-06-30 | 1336000 | 23512000 Derived | -22176000 | 407000 Derived | -22583000 | -19829000 Derived | Source
|
| 2026 2025-07-01 – 2026-06-30 | 1016000 | 25954000 Derived | -24938000 | -1117000 Derived | -23821000 | -20221000 Derived | Source
|
Amounts are exact, in uref_410714697.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(uref_410714697) | Source evidence |
|---|---|---|---|
| 2025 | Revenue | 1336000 |
|
| 2026 | Revenue | 1016000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Year over year | No prior comparable period |
|
| 2026 | Year over year | -24% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Operating margin | -1,659.9% |
|
| 2026 | Operating margin | -2,454.5% |
|
| 2025 | Net margin | -1,690.3% |
|
| 2026 | Net margin | -2,344.6% |
|
| 2025 | Free cash flow margin | -1,484.2% |
|
| 2026 | Free cash flow margin | -1,990.3% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(uref_410714697) | Source evidence |
|---|---|---|---|
| 2025 | Operating cash flow | -18211000 |
|
| 2026 | Operating cash flow | -19588000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(uref_410714697) | Source evidence |
|---|---|---|---|
| 2025 | Free cash flow | -19829000 |
|
| 2026 | Free cash flow | -20221000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025-06-30 | Liabilities / assets | Not reported |
|
| 2026-06-30 | Liabilities / assets | Not reported |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Current assets / current liabilities | 0.68× |
|
| 2026 | Current assets / current liabilities | 0.27× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2025 2024-07-01 – 2025-06-30 | −uref_410714697 22.58 million Exact valueExact value: -22583000 uref_410714697 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −uref_410714697 18.21 million Exact valueExact value: -18211000 uref_410714697 Share or citeThe citation records this snapshot. The page link may show a newer release later. | uref_410714697 1.62 million Exact valueExact value: 1618000 uref_410714697 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −uref_410714697 19.83 million Calculation and evidence-18211000 − 1618000 uref_410714697 Exact free cash flow: -19829000 uref_410714697
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-07-01 – 2026-06-30 | −uref_410714697 23.82 million Exact valueExact value: -23821000 uref_410714697 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −uref_410714697 19.59 million Exact valueExact value: -19588000 uref_410714697 Share or citeThe citation records this snapshot. The page link may show a newer release later. | uref_410714697 633,000 Exact valueExact value: 633000 uref_410714697 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −uref_410714697 20.22 million Calculation and evidence-19588000 − 633000 uref_410714697 Exact free cash flow: -20221000 uref_410714697
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
123 filings · 3,545 latest values · 3,545 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001158780, 1158780, PLUR, PSTI, edgar:1158780
Also known as AI SOFTWARE INC, PLURI INC., PLURI INC., PLURISTEM LIFE SYSTEMS INC, PLURISTEM THERAPEUTICS INC, PLURISTEM THERAPEUTICS INC., Pluri Inc.